Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Novo’s semaglutide beats Lilly’s Trulicity in diabetes contest

Analysts predict the drug could be worth $8.7bn in the next five years

- PMLiVE

Type 2 diabetes market set to soar to $64bn by 2026

Rising prevalence, progressive nature and diagnosis of the condition behind the surge

- PMLiVE

Takeda unveil final chapters of first graphic novel The Unbeatables

Partners with Marvel to complete the graphic novel as a part of its IBD Unmasked initiative

- PMLiVE

Novo Nordisk bolsters management team

Appoints Camilla Sylvest and Doug Langa

- PMLiVE

Lucid’s Creative Services team grows

A vital part to delivering exceptional medical education programmes is the design of clever branding and engaging visual elements. Lucid Group pride themselves in the quality of their digital and...

Lucid Group Communications Limited

- PMLiVE

WA Health wins Merck account

Communications agency will drive Merck’s UK reach

- PMLiVE

UCB collaborates with UK’s Medical Research Council

The partners will support researchers developing antibody-based therapeutics

Bristol-Myers Squibb (BMS) building

BMS data add to checkpoint inhibitor combo confusion

Opdivo and Yervoy meet one objective but miss another in CheckMate-214

- PMLiVE

FDA knocks-back second Vernalis cough and cold treatment

US regulator delivers another complete response letter to the UK firm

- PMLiVE

Navigating the social media waters in healthcare

Regulations shouldn't prevent creative and engaging social media content

Shire Basingstoke

Shire files dry eye drug lifitegrast in Europe

Analysts predict Xiidra could become a $1bn product

Beacons for genuinely patient-centric marketing

How pharma marketing can respond to patient-centricity

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links